Starting on:
May 6, 2024
Ending on:
May 7, 2024
Moderator(s):
Moi Teaching and Referral Hospital through AMPATH Multiple Myeloma Program
Max Credits:
10 Points
Provider:
FOUNTAIN HEALTHCARE
Claim Points
May 6, 2024
Ending on:
May 7, 2024
Moderator(s):
Dr.
BEATRICE MELLY
Clinical Hematoncologist MTRH Principal Investigator AMPATH Multiple Myeloma Program
Venue: Clinical Hematoncologist MTRH Principal Investigator AMPATH Multiple Myeloma Program
Moi Teaching and Referral Hospital through AMPATH Multiple Myeloma Program
Max Credits:
10 Points
Provider:
FOUNTAIN HEALTHCARE
Claim Points
BISPECIFIC AGENTS IN MULTIPLE MYELOMA
Starting on:
May 6, 2024
May 6, 2024
Ending on:
May 7, 2024
May 7, 2024
Venue:
Moi Teaching and Referral Hospital through AMPATH Multiple Myeloma Program
Moi Teaching and Referral Hospital through AMPATH Multiple Myeloma Program
Description
To discuss multiple myeloma treatment trajectory; the bispecific agents in multiple myeloma and the availability of therapeutic options for patients with relapsed or refractory multiple myeloma
Objectives
To discuss multiple myeloma treatment trajectory
To establish bispecific agents in multiple myeloma
To discuss the availability of therapeutic options for patients with relapsed or refractory multiple myeloma
Presenters
-
Dr.
ATTAYA SUVANNASANKHA
Associate Professor of Clinical Medicine, Department of Medicine, Division of Hematology/Oncology, IU School of Medicine Indiana University Melvin and Bren Simon Comprehensive Cancer Center Co-Leader of the Multiple Myeloma Program
Indiana University, Indianapolis, USA